Elevance Health

ELV

Market cap $64.5B

NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Elevance Health, Inc. (ELV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) and the National Diaper Bank Network (NDBN) today announced a new national pilot program designed to expand access to diapers for families with infants and young children, helping reduce financial strain while generating evidence on how meeting basic material needs can improve maternal and child health outcomes. The 12-month pilot program will provide free diapers to up to 75 families per month at 10 Welcome Rooms operated by Elevance H.

SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Elevance Health, Inc. (NYSE: ELV). The investigation focuses on whether Elevance and its executive officers complied with federal securities laws.

The agency plans to suspend enrollment of beneficiaries into certain Medicare Advantage plans, Elevance says.

The Centers for Medicare & Medicaid Services has notified Elevance Health it plans to impose sanctions that would stop the health insurer from enrolling members in its Medicare Advantage prescription drug plans, a filing showed on Monday.

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) today announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits. As part of these changes, Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon, the Company's healthcare services operations including pharmacy services, behavioral health, value-based care, and care delivery capabilities. C.

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation has awarded 22 new grants totaling more than $2.3 million to support food as medicine programs across the country. These grants will help nonprofit organizations improve access to nutritious food and advance clinical outcomes for individuals and families experiencing food and nutrition insecurity, particularly those living with diet-related chronic conditions. This latest round of funding is part of the Foundation's five-year, $150 milli.